TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

25 hedge funds and large institutions have $16.4M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$162K
2
Stifel Financial
2
Stifel Financial
Missouri
$144K
3
CAM
3
ClariVest Asset Management
California
$247K
4
BFA
4
BlackRock Fund Advisors
California
$89K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$835K

Top Sellers

1
DM
1
Deerfield Management
New York
$296K
2
VAM
2
Visium Asset Management
New York
$405K
3
WG
3
Welch Group
Alabama
$0
4
CS
4
Candriam SCA
Luxembourg
$626K
5
Wells Fargo
5
Wells Fargo
California
$66K
Name Holding Trade Value Shares
Change 		Shares
Change %
WG
26
Welch Group
Alabama
– -$418K -299 Closed
1
2